1. Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing.
- Author
-
Song YX, Xin RL, Li ZC, Yu HW, Lun WH, Ye J, Liu A, Li AX, Li JW, Ye JZ, Hao MQ, Lu HY, and Sun LJ
- Subjects
- Acquired Immunodeficiency Syndrome transmission, Adolescent, Adult, Aged, Aged, 80 and over, Beijing epidemiology, HIV-1 genetics, HIV-1 physiology, Homosexuality, Male, Humans, Male, Middle Aged, Mutation, Prevalence, Young Adult, Acquired Immunodeficiency Syndrome epidemiology, Anti-HIV Agents pharmacology, Drug Resistance, Viral genetics, HIV-1 drug effects, Protease Inhibitors pharmacology, Reverse Transcriptase Inhibitors pharmacology
- Abstract
To optimise patients' outcomes and gain insight into transmitted drug resistance (TDR) among human immunodeficiency virus (HIV)-1 treatment-naive patients in Beijing, the prevalence of TDR was assessed. Demographic and clinical data of 1241 treatment-naive patients diagnosed between April 2014 and February 2015 were collected. TDR was defined using the Stanford University HIV drug resistance mutations database. The risk factors were evaluated by multi-logistic regression analysis. Among 932 successfully amplified cases, most were male (96.78%) and infected through men having sex with men (91.74%). Genotype were CRF01_AE (56.44%), B (20.60%), CRF07_BC (19.96%), C (1.61%) and other genotypes (1.39%). The overall prevalence of TDR was 6.12%. Most frequent mutations occurred in non-nucleoside reverse transcriptase inhibitors (NNRTIs) (3.11%), followed by protease inhibitors (PIs) (2.25%) and nucleoside reverse transcriptase inhibitors (NRTIs) (1.32%). Furthermore, HIV-1 genotype was associated with high risk of resistance, in which genotype C and other genotype may have higher risk for resistance. The prevalence among treatment-naive patients in Beijing was low. Resistance to NNRTIs was higher than with PIs or NRTIs. Continuous monitoring of regional levels of HIV-1 TDRs would contribute to improve treatment outcomes and prevent failures.
- Published
- 2018
- Full Text
- View/download PDF